CB-64D AND CB-184 - LIGANDS WITH HIGH SIGMA(2) RECEPTOR AFFINITY AND SUBTYPE SELECTIVITY

被引:52
作者
BOWEN, WD
BERTHA, CM
VILNER, BJ
RICE, KC
机构
[1] Laboratory of Medicinal Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda
关键词
SIGMA RECEPTOR; (SUBTYPE SELECTIVITY); PHENYLMORPHAN; OPIOID;
D O I
10.1016/0014-2999(95)00176-L
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Four members of a novel class of sigma (a) ligands were investigated for a subtype selectivity. (-)-1S,5S- and (+)-1R,5R-(E)-8-Benzylidene-5-(3-hydroxyphenyl)-2-methylmorphan-7-one (CB-64L and CB-64D, respectively) exhibited sigma(1) K-i=10.5 nM and 3063 nM; sigma(2) K-i=154 nM and 16.5 nM, respectively. The corresponding 3,4-dichloro derivatives, (-)-1S,5S- and (+)-1R,5R-(E)-8-(3,4-dichiorobenzylidene)-5-(3-hydroxyphenyl)-2-methylmorphan-7-one (CB-182 and CB-184, respectively) were also examined. CB-182 ((-)-isomer) showed sigma(1) and sigma(2) K-i=27.3 nM and 35.5 nM, respectively, whereas CB-184 ((+)-isomer) exhibited sigma(1) and sigma(2) K-i=7436 nM and 13.4 nM, respectively. Thus, the two a subtypes showed opposite enantioselectivity for these compounds, with(-)>(+) at sigma(1) and(+)>(-) at sigma(2). Importantly, CB-64D and CB-184 showed high sigma(2) affinity and, respectively, 185-fold and 554-fold selectivity for sigma(2) receptors over sigma(1). While high sigma(2) selectivity relative to sigma(1) was achieved with these compounds, they both exhibited high affinity at mu (mu) opioid receptors (K-i=37.6 nM and 4.5 nM, respectively). Despite this, CB-64D and CB-184 will be useful tools for further characterization of sigma(2) receptors.
引用
收藏
页码:257 / 260
页数:4
相关论文
共 12 条
  • [1] A MARKED CHANGE OF RECEPTOR AFFINITY OF THE 2-METHYL-5-(3-HYDROXYPHENYL)MORPHANS UPON ATTACHMENT OF AN (E)-8-BENZYLIDENE MOIETY - SYNTHESIS AND EVALUATION OF A NEW CLASS OF SIGMA-RECEPTOR LIGANDS
    BERTHA, CM
    MATTSON, MV
    FLIPPENANDERSON, JL
    ROTHMAN, RB
    XU, H
    CHA, XY
    BECKETTS, K
    RICE, KC
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (19) : 3163 - 3170
  • [2] BONHAUS DW, 1993, J PHARMACOL EXP THER, V267, P961
  • [3] Bowen Wayne D., 1993, Molecular Neuropharmacology, V3, P117
  • [4] De Costa B. R., 1994, SIGMA RECEPTORS, P45
  • [5] A NEW APPROACH TO THE DESIGN OF SIGMA-2-SELECTIVE LIGANDS - SYNTHESIS AND EVALUATION OF N-[2-(3,4-DICHLOROPHENYL)ETHYL]-N-METHYL-2(1-PYRROLIDINYL)ETHYLAMINE-RELATED POLYAMINES AT SIGMA-1 AND SIGMA-2 RECEPTOR SUBTYPES
    DECOSTA, BR
    HE, XS
    DOMINGUEZ, C
    CUTTS, J
    WILLIAMS, W
    BOWEN, WD
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (02) : 314 - 321
  • [6] PHENYLMORPHANS AND ANALOGS - OPIOID RECEPTOR SUBTYPE SELECTIVITY AND EFFECT OF CONFORMATION ON ACTIVITY
    FROIMOWITZ, M
    PICK, CG
    PASTERNAK, GW
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (09) : 1521 - 1525
  • [7] A SIGMA-LIKE BINDING-SITE IN RAT PHEOCHROMOCYTOMA (PC12) CELLS - DECREASED AFFINITY FOR (+)-BENZOMORPHANS AND LOWER MOLECULAR-WEIGHT SUGGEST A DIFFERENT SIGMA RECEPTOR FORM FROM THAT OF GUINEA-PIG BRAIN
    HELLEWELL, SB
    BOWEN, WD
    [J]. BRAIN RESEARCH, 1990, 527 (02) : 244 - 253
  • [8] RAT-LIVER AND KIDNEY CONTAIN HIGH-DENSITIES OF SIGMA(1) AND SIGMA(2) RECEPTORS - CHARACTERIZATION BY LIGAND-BINDING AND PHOTOAFFINITY-LABELING
    HELLEWELL, SB
    BRUCE, A
    FEINSTEIN, G
    ORRINGER, J
    WILLIAMS, W
    BOWEN, WD
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 268 (01): : 9 - 18
  • [9] OPTICAL ISOMERS OF MISCELLANEOUS STRONG ANALGETICS
    MAY, EL
    TAKEDA, M
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1970, 13 (05) : 805 - &
  • [10] SYNTHESIS AND INVITRO EVALUATION OF 5,6,7,8,9,10-HEXAHYDRO-7,10-IMINOCYCLOHEPT[B]INDOLES - HIGH-AFFINITY LIGANDS FOR THE N,N'-DI-O-TOLYLGUANIDINE-LABELED SIGMA BINDING-SITE
    MEWSHAW, RE
    SHERRILL, RG
    MATHEW, RM
    KAISER, C
    BAILEY, MA
    KARBON, EW
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (03) : 343 - 352